.Different fromnormalbloodvessel,RNVisdefectiveinendothelial function [2] . Endothelialprogenitorcells(EPCs)aretheprecursorcellsof vascularendothelialcellswithhighproliferativepotential and endotheliumcharacteristic.Theyareoneofthe importantprotectivefactorsofvascularendothelialfunctions [3] . Currently,EPCstransplantationhasbeenusedinthe treatmentofmyocardialinfarctionandothercoronaryheart diseases,stroke,diabeticmicrovasculopathies,andischemic
www.ijo.cn 栽藻造押8629原愿圆圆源缘员苑圆 8629-82210956 耘皂葬蚤造押ijopress 岳员远猿援糟燥皂 retinopathieswithpreferablecurativeeffects [4] [5] .Inthefield ofROP,itwasinvestigatedthatEPCsnotonlyparticipated inretinalangiogenesisprocessinbothphysiologicaland pathologicalconditions,butalsoplayedanimportantrolein theanimalmodel [6] [7] [8] [9] [10] [11] [12] .Basedontheabove,wetransplanteda sufficientamountofEPCswitheffectivefunctionsinto vitreousbodiesofmicewithretinalischemiaandhypoxiato observetheeffect. SUBJECTSANDMETHODS EndothelialProgenitorCellsIsolationandCulture EPCs wereisolatedfromhumanumbilicalcordbloodusingthe methodofourlab [13] [14] . [15] ,littersof postnatalday(P)7micewereplacedtohyperoxia(mixed gaswith75%oxygenand25%nitrogen)chamberfor5d fromP7toP12.The12miceofnormalcontrolgroup(NC group,24eyes)werealwayslivinginroomair. EndothelialProgenitorCellsLabelingandIntravitreal InjectionProcedure Onday10,mostcellsshowedthe formofelongatedcobblestones.EPCswerelabeledwith 5 滋mol/L5-(and-6)-carboxyfluoresceindiacetatesuccinimidyl ester(CFSE,MolecularProbesBiotec.Co.).Thisconcentration wasprovedtobetheoptimalforEPCslabelinginourlab [14] . EPCsweredilutedinto2伊10 5 cells/滋Lfortransplantation. AtP12,OIRmicewereanesthetizedbyintraperitoneal injectionofchloralhydrate(3 滋g/10gbodyweight)and pupilsweredilatedwithtroicamide(0.5%).Asdescribedby Greenberg [16] ,injectionwiththevolumeof1滋 Lwas ablunt33-gaugeneedleattachedtoa10-滋Lglass syringe(HamiltonCompany,Reno,NV,USA).The48OIR animals (48eyes)wereintravitreallyinjectedwithCFSE labeledEPCs(EPCsgroup,30eyes)orwithPBS(PBS group,18eyes).IneveryOIRanimal,thecontralateraleye servedasacontrolandreceivednoinjection(OIRgroup,48 eyes).NoinjectionwasperformedoneacheyeofNCgroup (24eyes). 
DISCUSSION
ROPcouldresultinpathologicvascularizationofretina, whichfrequentlyleadstononreversiblevisualacuity decrease.Smith [15] establishedtheOIRmodelcouldbe easilysetupandusedtoevaluatethequalitativeand quantitativechanges.Toevaluatetheextentofretinopathyof OIR,Liu [18] performedADPasestaininginretinal wholemounts,countedthenumbersofneovascularnuclei, vessellumens,andnon-ganglioncells.Accordingtotheir study,forOIRmice,thecountsofnon-ganglioncellsand neovascularnucleiincreasedsignificantlyatP17with disorganizeddistributioninmorethanonelayerwithinor crossingtheinnerlimitingmembrane [18] .Comparedwiththe normalcontrolgroup,forOIRmice,non-ganglioncells increasedby1.50-foldhigheratP14,peakedby3.14-fold higheratP17,andregressedmoderatelyby1.55-foldhigher atP21,andincreasedproliferationofneovascularnucleiwas detectedatP17 [18] . InviewoftheclassicresearchesaboutOIR,thegreatest neovascularresponsewasshownupfromP17toP21 [15] .And accordingtothepreviousstudyofourlab [14] ,whichwas abouttherepaireffectofEPCsintravitrealtransplantationon thephotocoagulationinjurymicemodel,oneweekwaslong enoughfortheinjectedEPCstocongregatearoundthe retinopathy.SowechoseP12astheinjectedtimepointand P19astheobservationtimepoint.InOIRmiceofour research,theinhibited developmentoftheretinal vascularizationwasdetectedatP12,andvascularocclusion withnonperfusionareasandneovasculartuftscouldbeseen atP19.ReferringtothechangesofretinalcellsinOIRmice atP19,thenon-ganglioncellswithvariousnucleiandalso someneovascularnucleiincreaseddramatically.The distributionswerealsodisorganized.Thesefindingswere similartotheformerstudyatP17 [18] . Atpresent,forthecelltherapyofretinaldiseases,thereare differenttypesofstemcells.Forexample,mononuclearcells weretransplantedintravitreouslyfordiabeticretinopathy [19] , opticnerveatrophy [19] [20] ,age-relatedmaculardegeneration [19] , retinitispigmentosa [21] [22] [23] andischemicretinopathy [23] in human.Sofar,therehavebeenvariouseffectivetreatments forROPwhichcouldholdbacktheprogressionofROP [4, [24] [25] . Nakagawa [6] 
